Notices. Notice
1,404 words·~6 min read·
/register/2006/03/15/06-2542·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 6560-50-S ENVIRONMENTAL PROTECTION AGENCY [EPA-HQ-OPPT-2003-0006; FRL-7765-6] TSCA Chemical Testing; Receipt of Test Data AGENCY: Environmental Protection Agency (EPA). ACTION: Notice. SUMMARY: This notice announces EPA's receipt of test data regarding *In Vitro* Dermal Absorption Rate Testing of certain chemicals of interest to the Occupational Safety and Health Administration (OSHA). EPA received data on the following chemicals: Acetonitrile (CAS No. 75-05-8); methyl acetate (CAS No. 79-20-9); propylene dichloride (CAS No. 78-87-5); p-nitroaniline (CAS No. 100-01-6); pentane (CAS No. 109-66-0); n-heptane (CAS No. 142-82-5); and tetrahydrofuran (CAS No. 109-99-9).
These data were submitted pursuant to a test rule issued by EPA under section 4 of the Toxic Substances Control Act (TSCA). FOR FURTHER INFORMATION CONTACT: Colby Lintner, Regulatory Coordinator, Environmental Assistance Division (7408M), Office of Pollution Prevention and Toxics, Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone number:
(202)554-1404; e-mail address: *TSCA-Hotline@epa.gov* . SUPPLEMENTARY INFORMATION: I. General Information A. Does this Action Apply to Me? This action is directed to the public in general. This action may, however, be of interest to those persons who are concerned about data on health and/or environmental effects and other characteristics of these chemicals. Since other entities may also be interested, the Agency has not attempted to describe all the specific entities that may be affected by this action. If you have any questions regarding the applicability of this action to a particular entity, consult the person listed under FOR FURTHER INFORMATION CONTACT . B. How Can I Get Copies of this Document and Other Related Information? 1. *Docket.* EPA has established a docket for this action under docket identification
(ID)number EPA-HQ-OPPT-2003-0006. Publicly available docket materials are available electronically at *http://www.regulations.gov* or in hard copy at the OPPT Docket, EPA Docket Center (EPA/DC), EPA West, Room B102, 1301 Constitution Ave., NW., Washington, DC. The EPA Docket Center Public Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal holidays. The telephone number for the Public Reading Room is
(202)566-1744, and the telephone number for the OPPT Docket is
(202)566-0280. 2. *Electronic access* . You may access this **Federal Register** document electronically through the EPA Internet under the “ **Federal Register** ” listings at *http://www.epa.gov/fedrgstr/* . II. Test Data Submissions Section 4(d) of TSCA requires EPA to publish a notice in the **Federal Register** reporting the receipt of test data submitted pursuant to test rules promulgated under section 4(a) within 15 days after these data are received by EPA. 1. Test data for acetonitrile were submitted by DuPont Chemical Solutions Enterprise and received by EPA on November 7, 2005. The submission includes a final study report titled: “Acetonitrile: *In Vitro* Dermal Absorption Rate Testing.” (See Document ID No. EPA-HQ-2003-0006-0309). 2. Test data for methyl acetate were submitted by the American Chemistry Council and received by EPA on November 21, 2005. The submission includes a final study report titled: “Methyl Acetate: *In Vitro* Dermal Absorption Rate Testing.” (See Document ID No. EPA-HQ-2003-0006-0315). 3. Test data for propylene dichloride were submitted by The Dow Chemical Company and received by EPA on December 14, 2005. The submission includes a final study report titled: “Propylene Dichloride: *In Vitro* Dermal Absorption Rate Testing.” (See Document ID No. EPA-HQ-2003-0006-0319). 4. Test data for p-nitroaniline were submitted by Aceto Corporation and received by EPA on December 27, 2005. The submission includes a final study report titled: “Human Percutaneous Absorption and Cutaneous Disposition of [ 14 C]-Nitroaniline *In Vitro* .” (See Document ID No. EPA-HQ-2003-0006-0320). 5. Test data for pentane were submitted by the Alkanes Dermal Absorption Consortium of the American Chemistry Council and received by EPA on December 29, 2005. The submission includes a final study report titled: “Pentane: *In Vitro* Dermal Absorption Rate Testing.” (See Document ID No. EPA-HQ-2003-0006-0322. This document also contains the results of *In Vitro* Dermal Absorption Rate Testing for n-heptane). 6. Test data for n-heptane were submitted by the Alkanes Dermal Absorption Consortium of the American Chemistry Council and received by EPA on December 29, 2005. The submission includes a final study report titled: “n-Heptane: *In Vitro* Dermal Absorption Rate Testing.” (See Document ID No. EPA-HQ-2003-0006-0322. This document also contains the results of *In Vitro* Dermal Absorption Rate Testing of pentane). 7. Test data for tetrahydrofuran were submitted by the Tetrahydrofuran Task Force
(TTF)and received by EPA on November 23, 2005. The submission includes a final study report titled “Determination of the Percutaneous Absorption of THF, *In Vitro* , Using the Human Cadaver Skin Model.” (See Document ID No. EPA-HQ-2003-0006-0323). These chemical substances are used in a wide variety of applications as industrial solvents, which may result in exposures of a substantial number of workers as described in the support document for the proposed rule (64 FR 31074, June 9, 1999, Table 3-Exposure Information for Chemical Substances). EPA has initiated its review and evaluation process for these submissions. At this time, the Agency is unable to provide any determination as to the completeness of the submissions. Authority: 15 U.S.C. 2603. List of Subjects Environmental protection, Hazardous substances. March 2, 2006. Jim Willis, Director, Chemical Control Division, Office of Pollution Prevention and Toxics. [FR Doc. E6-3586 Filed 3-14-06; 8:45 am] BILLING CODE 6560-50-S OFFICE OF SCIENCE AND TECHNOLOGY POLICY Meeting of the President's Council of Advisors on Science and Technology ACTION: Notice of meeting. SUMMARY: This notice sets forth the schedule and summary agenda for a meeting of the President's Council of Advisors on Science and Technology (PCAST), and describes the functions of the Council. Notice of this meeting is required under the Federal Advisory Committee Act (FACA). Dates and Place: March 28, 2006, Washington, DC. The meeting will be held in the Grand Ballroom of the George Washington University Marvin Center Building, 800 21st St. NW., Washington DC 20052. *Type of Meeting:* Open. Further details on the meeting agenda will be posted on the PCAST Web site at *http://www.ostp.gov/PCAST/pcast.html.* *Proposed Schedule and Agenda:* The President's Council of Advisors on Science and Technology is scheduled to meet in open session on Tuesday March 28, 2006, at approximately 9 a.m. The PCAST is tentatively scheduled to hear a presentation on the Federal Networking and Information Technology Research and Development (NITRD) program as part of its review of that program. The PCAST also is tentatively scheduled to hear presentations relating to its ongoing study of energy technologies and to discuss draft recommendations for a forthcoming report. An update of other PCAST topics ( *e.g.* , nanotechnology) and a briefing on the President's American Competitiveness Initiative and the National Science Foundation's 2006 Science and Engineering Indicators report are also tentatively scheduled to occur. This session will end at approximately 5 p.m. Additional information and the final agenda will be posted at the PCAST Web site at: *http://www.ostp.gov/PCAST/pcast.html.* *Public Comments:* There will be time allocated for the public to speak on the above agenda items. This public comment time is designed for substantive commentary on PCAST's work topics, not for business marketing purposes. Please submit a request for the opportunity to make a public comment five
(5)days in advance of the meeting. The time for public comments will be limited to no more than 5 minutes per person. Written comments are also welcome at any time following the meeting. Please notify Celia Merzbacher, PCAST Executive Director, at
(202)456-7116, or fax your request/comments to
(202)456-6021. FOR FURTHER INFORMATION CONTACT: For information regarding time, place and agenda, please call Celia Merzbacher at
(202)456-7116, prior to 3 p.m. on Friday, March 24, 2006. Information will also be available at the PCAST Web site at: *http://www.ostp.gov/PCAST/pcast.html.* Please note that public seating for this meeting is limited and is available on a first-come, first-served basis. SUPPLEMENTARY INFORMATION: The President's Council of Advisors on Science and Technology was established by Executive Order 13226, on September 30, 2001. The purpose of PCAST is to advise the President on matters of science and technology policy, and to assist the President's National Science and Technology council in securing private sector participation in its activities. The Council members are distinguished individuals appointed by the President from non-Federal sectors. The PCAST is co-chaired by Dr. John H. Marburger, III, the Director of the Office of Science and Technology Policy, and by E. Floyd Kvamme, a Partner at Kleiner Perkins Caufield & Byers. Celia Merzbacher, PCAST Executive Director, Office of Science and Technology Policy. [FR Doc. 06-2542 Filed 3-14-06; 8:45 am]
Connectionstraces to 2
Traces to 2 documents
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources